Zenith Health Care Share News - Latest Updates, Live News & More

Latest news about Zenith Health Care

Zenith Health Care reappoints Neela M. Raycha as non-executive director Aug 31, 2026

Zenith Health Care reappoints Neela M. Raycha as Non-Executive Director. She retires by rotation and offers herself for re-appointment under SEBI Reg 30. Raycha holds 1,261,712 shares and is the spouse of the CMD. Her expertise lies in quality control and product development.

Zenith Health Care re-appoints Mahendra C. Raycha as MD for three years Aug 31, 2026

Zenith Health Care Q1 Results: Net profit turns positive at ₹13.62 lakh Aug 19, 2026

Zenith Health Care sets August 28 for 32nd AGM with e-voting Aug 05, 2026

Zenith Health Care seeks CMD re-appointment, ₹100 crore RPT at AGM Aug 04, 2026

More news about Zenith Health Care

15Jul 26

Zenith Health Care approves amalgamation with Achyut Healthcare

Zenith Health Care approved amalgamating Achyut Healthcare to boost efficiency and simplify structure. The deal involves issuing 119 shares for every 50 shares held, pending regulatory approvals.

29May 26

Zenith Healthcare FY26 profit falls, appoints auditor

Zenith Health Care reported a decline in net profit to ₹0.51 lakh for FY26, with revenue dropping to ₹1,052.22 lakh. Q4FY26 resulted in a net loss of ₹34.20 lakh. The Board re-appointed Mr. Akshit Mahendra Raycha as Joint Managing Director for three years and appointed Mr. Tanaykumar Mohta as Internal Auditor for the financial year 2026-27.

11Apr 26

Zenith Healthcare Limited Declares Non-Applicability of Large Corporate Disclosure Requirements for FY26

Zenith Healthcare Limited submitted a declaration to BSE on April 11, 2026, confirming it does not qualify as a 'Large Corporate' under SEBI Circular SEBI/HO/DDHS/CIR/P/144 for FY26. The company reported nil outstanding borrowings as of March 31, 2026, and confirmed non-applicability of debt securities disclosure requirements. The declaration was authorized by Chairman Mahendra C. Raycha, Company Secretary Mihir S. Shah, and CFO Prashant Gupta.

11Apr 26

Zenith Healthcare Limited Submits RTA Declaration for Quarter Ended March 31, 2026

Zenith Healthcare Limited filed its quarterly RTA declaration under Regulation 74(5) of Depositories and Participants Regulations 2018 for Q4 FY26 ended March 31, 2026. The company submitted the mandatory compliance document to BSE on April 11, 2026, along with a certificate from Bigshare Services Private Limited confirming proper handling of dematerialization processes and compliance with regulatory requirements.

12Feb 26

Zenith Healthcare Reports Strong Q3FY26 Turnaround with ₹22.41 Lakh Net Profit

Zenith Healthcare Limited reported a strong financial turnaround in Q3FY26 with net profit of ₹22.41 lakh compared to a loss of ₹29.22 lakh in Q3FY25. Revenue from operations increased to ₹248.30 lakh, while the nine-month period showed net profit of ₹34.71 lakh against previous year's loss of ₹4.27 lakh. The company demonstrated improved operational efficiency with reduced material costs and positive earnings per share of ₹0.042.

11Nov 25

Zenith Healthcare Reports Mixed Q2 Results with Revenue Dip, Profit Growth for H1 FY2026

Zenith Healthcare Limited released its Q2 FY2026 results, showing a 9.6% quarter-on-quarter decline in revenue to ₹302.79 crore and a 9.5% drop in net profit to ₹21.88 crore. However, half-yearly results were more positive, with H1 FY2026 revenue increasing 14% year-over-year to ₹638.58 crore and net profit surging 70.9% to ₹39.34 crore. The company's balance sheet remains strong with total equity of ₹752.92 lakh against total assets of ₹1,072.03 lakh. The Board approved these results on November 11, 2025.

Zenith Health Care

3.13

-0.13

(-3.99%)

1 Year Returns:-28.21%

Industry Peers

Sun Pharmaceutical

1,840.00

(-1.13%)

Divis Laboratories

9,322.00

(-1.23%)

Torrent Pharmaceuticals

4,965.50

(+0.72%)

Zydus Life Science

1,119.10

(+0.12%)

Cipla

1,366.00

(-0.53%)

Laurus Labs

1,969.00

(+1.23%)

Dr Reddys Laboratories

1,165.50

(+1.97%)

Aurobindo Pharma

1,679.80

(+0.68%)

Lupin

2,095.00

(+0.83%)

Mankind Pharma

2,280.00

(+1.86%)

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104